Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Blake

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The New England Journal of Medicine|April 25, 1991
Survival and quality of life among patients receiving unproven as compared with conventional cancer therapyB R Cassileth, E J Lusk, D Guerry, et al.
Nature|March 5, 1987
Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like coreR A Dixon, I S Sigal, E Rands, et al.
Biochemical and Biophysical Research Communications|September 24, 1999
Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cellsR M Parmar, W W Chan, M Dashkevicz, et al.
Cell|June 19, 1987
The carboxyl terminus of the hamster beta-adrenergic receptor expressed in mouse L cells is not required for receptor sequestrationC D Strader, I S Sigal, A D Blake, et al.
European Journal of Pharmacology|December 6, 2000
The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled statesJ Di Salvo, G E Koch, K E Johnson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The New England Journal of Medicine|April 25, 1991
Survival and quality of life among patients receiving unproven as compared with conventional cancer therapyB R Cassileth, E J Lusk, D Guerry, et al.
Nature|March 5, 1987
Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like coreR A Dixon, I S Sigal, E Rands, et al.
Biochemical and Biophysical Research Communications|September 24, 1999
Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cellsR M Parmar, W W Chan, M Dashkevicz, et al.
Cell|June 19, 1987
The carboxyl terminus of the hamster beta-adrenergic receptor expressed in mouse L cells is not required for receptor sequestrationC D Strader, I S Sigal, A D Blake, et al.
European Journal of Pharmacology|December 6, 2000
The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled statesJ Di Salvo, G E Koch, K E Johnson, et al.
Pageof 3